| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8222857 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
Weekly oral risedronate prevented BMD loss at 2 years and resulted in significant suppression of bone turnover biomarkers for 24 months for patients receiving RT plus 2 to 3Â years of ADT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Richard MD, Himu MD, Patrick MD, Tom MD, Rosario MD, Reinhold PhD, Lisa MD, Alex PhD, Cyril MD,